WAM
GWPH

Wealthspire Advisors (Maryland)’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-100
Closed -$11K – 2649
2018
Q1 		$11K Hold
100
– – ﹤0.01% 1553
2017
Q4 		$13K Buy
+100
New +$11.8K ﹤0.01% 1500

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s GWPH Position: Q2 2018 in Review

Wealthspire Advisors (Maryland) sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2018, closing a stake of 100 shares — an estimated $11K sold.

Wealthspire Advisors (Maryland) first reported a position in GWPH in Q4 2017 and held it in 2 quarters. The position peaked at $13K in Q4 2017. 254 funds tracked by Wall St. Rank hold GWPH as of Q2 2018.

  • Wealthspire Advisors (Maryland) reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2018 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 100 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2018, an estimated $11K.
  • Wealthspire Advisors (Maryland) first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 2 quarters.
  • Wealthspire Advisors (Maryland)'s GW Pharmaceuticals Plc American Depositary Shares position peaked at $13K in Q4 2017.
  • 254 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2018.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2018, filed 8 Aug 2018.